Cargando…
Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer
Prominin-1 (CD133) is one of the most important stem cell markers among various malignant tumor types, but the clinicopathological significance of CD133 expression in intrahepatic cholangiocarcinoma remains controversial. To the best of our knowledge, there have been no reports on extrahepatic bile...
Autores principales: | Mizukami, Tatsuzo, Kamachi, Hirofumi, Mitsuhashi, Tomoko, Einama, Takahiro, Hatanaka, Yutaka, Kamiyama, Toshiya, Taketomi, Akinobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202489/ https://www.ncbi.nlm.nih.gov/pubmed/30405779 http://dx.doi.org/10.3892/ol.2018.9499 |
Ejemplares similares
-
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
por: Mizukami, Tatsuzo, et al.
Publicado: (2014) -
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
por: Mizukami, Tatsuzo, et al.
Publicado: (2018) -
An intraductal papillary neoplasm of the bile duct mimicking a hemorrhagic hepatic cyst: a case report
por: Kakisaka, Tatsuhiko, et al.
Publicado: (2013) -
Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
por: Matsuzawa, Fumihiko, et al.
Publicado: (2021) -
Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)